Anzeige
Mehr »
Dienstag, 03.03.2026 - Börsentäglich über 12.000 News
Erste Psilocybin-Behandlungen laufen - warum steht Optimi noch bei Pennystock-Level?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0M103 | ISIN: BE0003874915 | Ticker-Symbol: 4A5
Tradegate
02.03.26 | 20:27
22,650 Euro
+0,44 % +0,100
Branche
Gesundheitswesen
Aktienmarkt
BEL Mid
AMX
1-Jahres-Chart
FAGRON NV Chart 1 Jahr
5-Tage-Chart
FAGRON NV 5-Tage-Chart
RealtimeGeldBriefZeit
22,50022,60002.03.
22,50022,60002.03.

Aktuelle News zur FAGRON Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FAGRON Aktie jetzt für 0€ handeln
FrFagron NV: Disclosure of a transparency notification from AOC Pharma S.à r.l.1
DoFagron NV: Fagron completes strategic acquisition of Pharmavit Europe, strengthening its leadership in high-growth nutraceutical ingredients across EMEA192Regulated information - inside information Nazareth (Belgium)/Rotterdam (The Netherlands), 26 February 2026 - 6:30PM Fagron completes strategic acquisition of Pharmavit Europe, strengthening its leadership...
► Artikel lesen
12.02.Fagron FY 2025 presentation slides: 9.1% organic growth fuels record results2
12.02.Fagron NV: Fagron continues its outstanding performance in FY 2025 with 9.2% topline growth and 10.9% increase in REBITDA177Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 12 February 2026 - 7AM CET Fagron continues its outstanding performance in FY 2025 with 9.2% topline growth and 10.9% increase...
► Artikel lesen
05.02.Fagron NV: Fagron obtains regulatory clearance for the acquisition of Vepakum in Brazil and completes the acquisition of Magilab in Hungary183Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 5 February 2026 Fagron obtains regulatory clearance for the acquisition of Vepakum in Brazil and completes...
► Artikel lesen
12.01.Fagron NV: Inside information: Fagron announces the completion of the acquisition of University Compounding Pharmacy in North America242Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 12 January 2026 - 7:00 AM CET Fagron announces the completion of the acquisition of University Compounding...
► Artikel lesen
09.01.Fagron NV: Disclosure of notification received from BNP Paribas5
06.01.Fagron NV: Fagron announces the completion of Purifarma241Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 January 2026 - 7:00 AM CET Fagron announces the completion of Purifarma Fagron, the leading global player...
► Artikel lesen
19.12.25Fagron: Zwei Akquisitionen stärken Geschäft in Asien und Brasilien2
19.12.25Fagron expands with two acquisitions in APAC and Brazil1
19.12.25Fagron NV: Fagron accelerates global expansion with two strategic acquisitions and a key North American licensing milestone295Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 19 December 2025 - 7:00 AM CET Fagron accelerates global expansion with two strategic acquisitions and a key...
► Artikel lesen
24.11.25Fagron Announces Acquisitions Of Amara And Magilab8
24.11.25Fagron NV: Fagron strengthens EMEA leadership with acquisitions in Poland and Hungary and announces key developments for its North American business270Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 24 November 2025 - 7:00 AM CET Fagron strengthens EMEA leadership with acquisitions in Poland and Hungary...
► Artikel lesen
14.11.25Fagron NV: Fagron completes share buy-back program1
07.11.25Fagron NV: Fagron's share buy-back program: Weekly update1
31.10.25Fagron NV: Fagron's share buy-back program: Weekly update2
24.10.25Fagron NV: Fagron's share buy-back program: Weekly update1
17.10.25Fagron NV: Fagron's share buy-back program: Weekly update2
09.10.25Fagron NV Q3 Revenue Up 6,4%; Backs FY25 Revenue Outlook; Announces Share Buyback1
09.10.25Fagron NV: Fagron reports solid third quarter performance with 6.4% revenue growth and confirms full year outlook279Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 9 October 2025 - 7:00 AM CET Fagron reports solid third quarter performance with 6.4% revenue growth and confirms...
► Artikel lesen
Weiter >>
27 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1